Physician profile
Satish Kumar Arora
NPI 1063480440
$10,674.34
in general payments reported to CMS, 2019-2025
36 companies · $31.88 in 2025
The $31.88 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,966 · 2020: $658 · 2021: $1,493 · 2022: $2,407 · 2023: $2,715 · 2024: $1,404 · 2025: $31.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,150.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,768.80 | 2019-2025 | Skyrizi, Rinvoq, Humira |
| Janssen Biotech, INC. | $1,262.28 | 2019-2024 | Stelara, Tremfya, Remicade |
| Takeda Pharmaceuticals U.S.A., INC. | $1,105.95 | 2019-2024 | Entyvio, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $981.94 | 2019-2024 | Trulance, Xifaxan |
| Gilead Sciences, INC. | $854.68 | 2019-2024 | Epclusa |
| Intercept Pharmaceuticals, INC. | $510.70 | 2019-2024 | Ocaliva |
| Celgene Corporation | $411.18 | 2022-2024 | Zeposia |
| Genzyme Corporation | $271.51 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $244.23 | 2021-2023 | Stelara |
| Ironwood Pharmaceuticals, INC | $235.24 | 2019-2022 | |
| Ardelyx, INC. | $230.86 | 2022-2024 | Ibsrela |
| Daiichi Sankyo INC. | $227.19 | 2020-2022 | |
| Pfizer INC. | $217.02 | 2019-2024 | |
| Olympus America INC. | $206.76 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $150.39 | 2022-2023 | Zeposia |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $137.81 | 2023-2024 | Hadlima, Renflexis |
| Merck Sharp & Dohme LLC | $133.28 | 2019-2021 | |
| Lilly USA, LLC | $106.79 | 2023-2024 | Omvoh |
| Qol Medical, LLC | $87.09 | 2019-2024 | Sucraid |
| Nestle Healthcare Nutrition INC. | $82.78 | 2021-2023 | |
| Boston Scientific Corporation | $73.74 | 2019 | |
| Romark Laboratories, Lc | $68.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $36.73 | 2023-2024 | Dupixent |
| Allergan, INC. | $36.57 | 2019 | |
| Phathom Pharmaceuticals, INC. | $34.50 | 2024 | Voquezna |
| Ucb, INC. | $30.85 | 2019 | |
| Amgen INC. | $28.15 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.24 | 2021 | |
| Vyaire Medical, INC. | $17.98 | 2022 | |
| Sandoz INC. | $17.96 | 2023 | Hyrimoz |
| Braintree Laboratories, INC. | $17.57 | 2021 | |
| Alfasigma USA, INC. | $15.72 | 2020 | |
| Aimmune Therapeutics, INC. | $14.63 | 2024 | |
| Fresenius Kabi USA, LLC | $13.51 | 2023 | Idacio |
| Redhill Biopharma INC. | $11.75 | 2021 | |
| Endo Pharmaceuticals INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satish Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.